article thumbnail

Is a lack of real-time data holding trials back?

pharmaphorum

It’s 2020 and the digital revolution is well on its way. Yet, for clinical trials worldwide, real-time access to data is not the norm – and that lack can create a cascading set of issues affecting every aspect of a study. Critical decisions are too often being made in a digital data vacuum. Potentially catastrophic setbacks.

article thumbnail

How data is crucial to the relaunch of the Cancer Moonshot

pharmaphorum

The Biobank was launched in 2020, with an initial aim of enrolling at least 1,000 patients with locally advanced or metastatic solid tumours and haematologic malignancies undergoing standard of care therapy. Building a bank. Facilitating patient understanding and consent. Informed consent is crucial to recruiting the patient to the study.

article thumbnail

Methodology to Define a Pharma 4.0™ Roadmap

ISPE

The key to data integrity compliance is a well-functioning data governance system 1 , 2 in which the data flow path for all business processes and equipment—such as in manufacturing, laboratory, and clinical studies—is fully understood and documented by a detailed process data flow map.